A new study has found that one in three early-stage breast cancer patients who received genomic testing when deciding about treatment options felt they did not fully understand their discussions with physicians about their test results and their risk of recurrence.
One third of breast cancer patients feel they do not fully understand their genomic testing results
March 14th, 2010 by Newspublichealth.com
Leave a Reply
Sorry, no posts matched your criteria.